Triggering of interferon gamma-primed macrophages by various known complement activators for nonspecific tumor cytotoxicity.
Five known complement activators were evaluated for their capacity to directly activate murine macrophages and to trigger activation of lymphokine primed macrophages for nonspecific tumor cytotoxicity. Bacterial lipopolysaccharide (LPS), Lipid A, polyinosinic-polycytidylic acid, cobra venom factor (CVF), and zymosan directly activated macrophages in a dose-dependent fashion at high concentrations. Subactivating concentrations of each of these agents were found to effectively trigger macrophages which were preprimed either by macrophage-activating factor or by murine recombinant interferon gamma for enhanced tumoricidal activity. An Fc receptor blockade with opsonized sheep erythrocytes abrogated LPS-mediated direct activation and triggering of interferon gamma-primed macrophages, but had no inhibitory effect on direct activation or triggering by CVF for nonspecific tumor cytotoxicity. This study characterizes the capacity of a diverse group of known complement activators to serve as second signal triggers for culmination of the activation process of interferon-primed macrophages for nonspecific tumoricidal activity. These findings suggest that complement activators may directly activate macrophages by stimulation of interferon beta production by macrophages for self-priming and, as we have shown, act as self-triggers. The putative role of macrophage-associated complement components in the activation process is discussed.
D000818:Animals; D003167:Complement Activation; D003602:Cytotoxicity, Immunologic; D004546:Elapid Venoms / Q000494:pharmacology; D066298:In Vitro Techniques; D007371:Interferon-gamma / Q000276:immunology*; D008050:Lipid A / Q000494:pharmacology; D008070:Lipopolysaccharides / Q000494:pharmacology; D008262:Macrophage Activation / Q000187:drug effects; D008297:Male; D051379:Mice; D009374:Neoplasms, Experimental / Q000276:immunology*; D011070:Poly I-C / Q000494:pharmacology; D011961:Receptors, Fc / Q000276:immunology; D015054:Zymosan / Q000494:pharmacology
D004546:Elapid Venoms; D008050:Lipid A; D008070:Lipopolysaccharides; D011961:Receptors, Fc; C016310:cobra venom factor; D007371:Interferon-gamma; D015054:Zymosan; D011070:Poly I-C